Stay updated on EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial page.

Latest updates to the EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 is now displayed. The earlier government funding/operating-status notice has been removed.SummaryDifference0.4%

- Check21 days agoChange DetectedSite-wide notice added regarding a funding lapse that may affect data currency and operations, and the page revision updated to v3.4.1 (replacing v3.4.0).SummaryDifference0.4%

- Check28 days agoChange DetectedNew study-record metadata appears: Results First Posted, Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and a site revision label Revision: v3.4.0. The previous items Results First Posted (Estimated), Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4 were removed.SummaryDifference0.3%

- Check42 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed, a minor metadata update with no changes to study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check64 days agoChange DetectedAdded a Locations section listing California as a location. Removed the California Locations entry and the HHS Vulnerability Disclosure section, and updated the page revision from v3.3.2 to v3.3.3.SummaryDifference0.2%

- Check85 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2.SummaryDifference0.0%

Stay in the know with updates to EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial page.